Newsroom

Bladder treatment co Vensica raises $500,000

Israeli startup Vensica is developing a needle-free, painless procedure for the delivery of Botox to treat overactive bladder. Israeli overactive bladder treatment company Vensica Medical, a portfolio company of Trendlines Medical, has closed a $500,000 financing round from a private foreign investor. Vensica is developing a needle-free, painless procedure for the delivery of Botox to treat overactive bladder. The company was founded in August 2014 and will use this investment for R&D and completion of device design. Overactive bladder (OAB) is [...]

Vensica Wins Innovation In Medtech DUBLIN – April 2016

The Official Networking and Conference App – Facilitating Partnering at the Innovation In Medtech Dublin 2016 event. This medical device industry investment and networking conference – which has earned the reputation as the top medtech investment conference in Europe – took place April 12-14, 2016, at the historic and centrally located Shelbourne Dublin Hotel, overlooking St. Stephen’s Green. DUBLIN 2016 was hosted by Innovation In Medtech, along with Platinum Sponsors Johnson & Johnson, Seroba, Enterprise Ireland, EY, and Eugene F. [...]

Vensica Medical Completes $500,000 Finance Round

MISGAV, Israel, July 19, 2016 /PRNewswire/ -- Vensica Medical, a portfolio company of Trendlines Medical, announced the completion of a financing round of US$500,000 from a private foreign investor. Vensica is developing a needle-free, painless procedure for the delivery of Botox® to treat overactive bladder. The company was founded in August 2014 and will use this investment for R&D and completion of device design. Overactive bladder (OAB) -- the most common type of bladder disorder is the urgent need to [...]